ALDX
Aldeyra Therapeutics, Inc.
0.93$
-1.9%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | – | – | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | 0.0% | 0.0% | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 16.9% | – | – | – | 26.3% | – | – | – | – | – | – | – | |
| – | 100.0% | 100.0% | – | – | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -16.9% | – | – | – | -26.3% | – | – | – | – | – | – | – | |
| – | 21.4% | 84.0% | – | – | 23.0% | 79.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,094.8% | – | – | – | 5,983.0% | – | – | – | – | – | – | – | |
| – | 7.5% | 43.0% | – | – | 6.2% | 22.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 458.3% | – | – | – | 796.5% | – | – | – | – | – | – | – | |
| – | 28.9% | 127.0% | – | – | 29.2% | 102.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,553.1% | – | – | – | 6,779.6% | – | – | – | – | – | – | – | |
| – | -28.9% | -127.0% | – | – | -29.2% | -102.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,553.1% | – | – | – | -6,779.6% | – | – | – | – | – | – | – | |
| – | 0.2% | 0.7% | – | – | 0.1% | 0.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 131.0% | – | – | – | 192.6% | – | – | – | – | – | – | – | |
| – | -28.9% | -126.9% | – | – | -28.8% | -101.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,210.6% | – | – | – | -6,465.1% | – | – | – | – | – | – | – | |
| – | 0.2% | 0.8% | – | – | 0.5% | 1.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -786.8% | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| – | -28.9% | -126.9% | – | – | -28.8% | -101.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,210.6% | – | – | – | -6,465.1% | – | – | – | – | – | – | – | |
| – | -28.6% | -126.0% | – | – | -28.7% | -100.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,062.7% | – | – | – | -6,246.2% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.